Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer

Wang, Qian, Liang, Ning, Yang, Tao, Li, Yuedan, Li, Jing, Huang, Qian, Wu, Chen, Sun, Ligang, Zhou, Xile, Cheng, Xiaobin, Zhao, Long, Wang, Gang, Chen, Zhangqian, He, Xianli, Liu, Chaoxu · 2021 · Journal of Hepatology

Abstract

BACKGROUND & AIMS Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) exhibit remarkable cancer stem cell (CSCs) features. Moreover, the development of both diseases is closely associated with the presence of CSCs. We investigated the role of brain-expressed X-linked protein 1 (BEX1) in regulating CSC properties of HB, and a subtype of HCC with high CSC features (CSC-HCC). METHODS Stemness scores were analyzed in five murine HCC models. A subpopulation of BEX1-positive cells and BEX1-negative cells were sorted from HCC cell lines, and subjected to transcriptome analysis. The expression and function of BEX1 was examined via western blotting, sphere formation assays, and xenograft tumor models. RESULTS We identified BEX1 as a novel CSC marker that was required for the self-renewal maintenance of liver CSCs. Furthermore, zebularine, a potent DNMT1 inhibitor, can induce the reactivation of BEX1 by removing epigenetic inhibition. Notably, BEX1 was highly expressed in HB and CSC-HCC patients, but exhibited a low expression in non-CSC HCC patients (non-CSC-HCC). Moreover, DNMT1-mediated methylation of the BEX1 promoter resulted in differential BEX1 expression patterns in HB, CSC-HCC, and non-CSC-HCC patients. Mechanistically, BEX1 established interaction with RUNX3 to block its inhibition of β-catenin transcription, which led to the activation of Wnt/β-catenin signaling, and stemness maintenance in both HB and CSC-HCC. In contrast, downregulated BEX1 expression released RUNX3 and inhibited the activation of Wnt/β-catenin signaling in non-CSC-HCC. CONCLUSION BEX1, under the regulation of DNMT1, is necessary for the self-renewal ability and maintenance of liver CSCs through activation of Wnt/β-catenin signaling, rendering BEX1 a valuable therapeutic target for both HB and CSC-HCC. LAY SUMMARY Cancer stem cells (CSCs) contribute to a high rate of cancer recurrence, as well as resistance to conventional therapies. However, the regulatory mechanisms underlying their self-renewal remains elusive. Here, we have reported that BEX1 plays a key role in regulating CSC properties in different types of liver cancer. Targeting BEX1-mediated Wnt/β-catenin signaling may help to address the high rate of recurrence, and heterogeneity of liver cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2021.06.025

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 188

Metadata

Authors
Wang, Q., Liang, N., Yang, T., Li, Y., Li, J., Huang, Q., Wu, C., Sun, L., Zhou, X., Cheng, X., Zhao, L., Wang, G., Chen, Z., He, X., & Liu, C.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2021-11
Volume
75
Issue
5
Pages
1142-1153
ISSN
0168-8278 (ISSN-L)
OpenAlex
W3177267538
Cited by
188
References
2
FWCI
10.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. https://app.cochat.ai/papers/10.1016/j.jhep.2021.06.025
The paper
Wang, Q., Liang, N., Yang, T., Li, Y., Li, J., Huang, Q., Wu, C., Sun, L., Zhou, X., Cheng, X., Zhao, L., Wang, G., Chen, Z., He, X., & Liu, C. (2021). DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2021.06.025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.